N-acetylcysteine Plus Deferoxamine for Patients With Hypotension
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
Oxidative stress is associated with kidney damage in several different situations, including
hypotension. In animal models it has been shown that the combination of n-acetylcysteine plus
deferoxamine is superior to its isolate use in the treatment of several diseases. Thus the
investigators aimed to determine if the administration of n-acetylcysteine plus deferoxamine
could prevent renal failure in critical ill patients who develops hypotension.
Phase:
Phase 2
Details
Lead Sponsor:
Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude
Collaborator:
Conselho Nacional de Desenvolvimento Científico e Tecnológico